Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
BMC Rheumatology
|
March 28, 2025
A case of digital vasculitis in anti-synthetase syndrome (Anti-OJ subtype)
Deniz Ak, Richard J Stratton
Matrix Biology : Journal of the International Society for Matrix Biology
|
January 30, 2025
George R. Martin: Pioneering matrix biologist
Andrew Leask, Richard J Stratton
Nature Reviews. Rheumatology
|
October 3, 2023
Back to the future: targeting the extracellular matrix to treat systemic sclerosis
Andrew Leask, Angha Naik, Richard J Stratton
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|
September 26, 2024
Digital ulcers associated with scleroderma: A major unmet medical need
Angha Naik, Richard J Stratton, Andrew Leask
Rheumatology (Oxford, England)
|
December 17, 2009
Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblasts
Xu Shi-wen, Mark Eastwood, Richard J Stratton, et al.
Journal of Cell Communication and Signaling
|
January 5, 2021
Verteporfin inhibits the persistent fibrotic phenotype of lesional scleroderma dermal fibroblasts
Xu Shi-Wen, Michael Racanelli, Aaisham Ali, et al.
Plos One
|
October 20, 2017
Antioxidants and NOX1/NOX4 inhibition blocks TGFβ1-induced CCN2 and α-SMA expression in dermal and gingival fibroblasts
Hannah Murphy-Marshman, Katherine Quensel, Xu Shi-Wen, et al.
The Journal of Investigative Dermatology
|
May 7, 2010
Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis
Nima Aden, Anna Nuttall, Xu Shiwen, et al.
Annals of the Rheumatic Diseases
|
June 16, 2023
<i>Tripterygium wilfordii</i> derivative celastrol, a YAP inhibitor, has antifibrotic effects in systemic sclerosis
Pratyusha Chitturi, Shiwen Xu, Bahja Ahmed Abdi, et al.
Matrix Biology Plus
|
February 5, 2021
CCN1 expression by fibroblasts is required for bleomycin-induced skin fibrosis
Katherine Quesnel, Xu Shi-Wen, James Hutchenreuther, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
BMC Rheumatology
|
March 28, 2025
A case of digital vasculitis in anti-synthetase syndrome (Anti-OJ subtype)
Deniz Ak, Richard J Stratton
Matrix Biology : Journal of the International Society for Matrix Biology
|
January 30, 2025
George R. Martin: Pioneering matrix biologist
Andrew Leask, Richard J Stratton
Nature Reviews. Rheumatology
|
October 3, 2023
Back to the future: targeting the extracellular matrix to treat systemic sclerosis
Andrew Leask, Angha Naik, Richard J Stratton
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|
September 26, 2024
Digital ulcers associated with scleroderma: A major unmet medical need
Angha Naik, Richard J Stratton, Andrew Leask
Rheumatology (Oxford, England)
|
December 17, 2009
Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblasts
Xu Shi-wen, Mark Eastwood, Richard J Stratton, et al.
Journal of Cell Communication and Signaling
|
January 5, 2021
Verteporfin inhibits the persistent fibrotic phenotype of lesional scleroderma dermal fibroblasts
Xu Shi-Wen, Michael Racanelli, Aaisham Ali, et al.
Plos One
|
October 20, 2017
Antioxidants and NOX1/NOX4 inhibition blocks TGFβ1-induced CCN2 and α-SMA expression in dermal and gingival fibroblasts
Hannah Murphy-Marshman, Katherine Quensel, Xu Shi-Wen, et al.
The Journal of Investigative Dermatology
|
May 7, 2010
Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis
Nima Aden, Anna Nuttall, Xu Shiwen, et al.
Annals of the Rheumatic Diseases
|
June 16, 2023
<i>Tripterygium wilfordii</i> derivative celastrol, a YAP inhibitor, has antifibrotic effects in systemic sclerosis
Pratyusha Chitturi, Shiwen Xu, Bahja Ahmed Abdi, et al.
Matrix Biology Plus
|
February 5, 2021
CCN1 expression by fibroblasts is required for bleomycin-induced skin fibrosis
Katherine Quesnel, Xu Shi-Wen, James Hutchenreuther, et al.
Page
of 2